New Patient Exam to Treatment Conversion Rate: What the Benchmark Is

The spread between a 45% case acceptance rate and a 61% one, on a practice that puts $720,000 of treatment in front of patients each year, is $115,200 of production you either scheduled or waved goodbye to. Most owners who go hunting for that money come back with a script, a new consult room, and the same number six months later, because they are measuring the wrong ratio in the wrong denominator over the wrong time window.

Here is the call, and you are welcome to fight us on it: if your new patient exam-to-treatment conversion rate is running above 85%, your problem is not closing. It is diagnosis. A 90% acceptance rate is not a sales record. It is a confession about what you are willing to bring up in the chair.

Four Studies, Four Numbers, and Why "The Benchmark" Is a Fiction

Go looking for the national benchmark and you will find at least four, none of which agree, because none of them are counting the same event.

• The Dental Economics and Levin Group Annual Practice Survey puts the national average case acceptance rate at 61%, roughly 30 percentage points under the 90% target consultants train toward.
• Henry Schein One's pooled practice data in the 2026 Catalyst Index lands lower, at about 45% industry-average treatment-plan acceptance, with the top 10% of practices around 75%.
• A peer-reviewed prosthodontic study found that only 18% of 200 patients accepted the treatment plan exactly as proposed. The other 82% declined it outright or picked something cheaper and smaller.
• In the National Dental Practice-Based Research Network, across 345 adults and 91 U.S. orthodontic providers, 78% of patients accepted the most highly recommended plan presented at the visit.

Eighteen to seventy-eight. That is not measurement noise, that is four different questions wearing the same label. The 61% is self-reported by dentists. The 45% is machine-counted out of practice management software, dollars accepted over dollars presented, which means it includes hygiene recall, emergency visits, and treatment plans that have been rotting in the system since 2023. The 18% is strict: did the patient take the plan as written, yes or no. The 78% came from a setting where one clearly ranked recommendation was put on the table.

So when someone asks us what the new patient exam-to-treatment conversion benchmark is, the honest answer is that the industry does not have one, and the number your software prints on the dashboard is not comparable to anyone else's. What you can benchmark is your own practice against itself, quarter over quarter, on a definition you write down and then refuse to change.

The Mistake: Counting Yeses Instead of Booked Chair Time

The specific error, and it is nearly universal among owner-dentists who run their own numbers off the monthly management report, is counting patients who said yes instead of dollars that got scheduled.

Watch what that does. Say 300 new patients a year leave the comprehensive exam with treatment diagnosed beyond preventive, at an average plan value of $2,400. That is $720,000 presented. Two hundred of them say yes to something, which your front desk reports as a 67% acceptance rate. But the average value of what they actually said yes to is $1,450, because the crown-and-buildup quadrant became one tooth and the night guard got deferred. That is $290,000 of the $720,000. Your real dollar conversion is 40%, not 67%.

The prosthodontic data is the warning label here: the dominant patient behavior is not refusal, it is downgrade. Eighty-two percent declined the plan or chose an alternate or lesser option. A yes-or-no counter cannot see that, and a practice managed on a yes-or-no counter will keep celebrating while production per new patient slides.

Then there is the second leak, the one that costs more and gets audited less. Verbal acceptance is not an appointment. If 20% of accepted treatment never makes it onto the schedule, or gets scheduled out past 90 days and quietly cancels, a practice with $439,200 in accepted treatment is really working with $351,360. That is $87,840 sitting in the software as a win.

Our view: verbal acceptance is not a metric, it is a feeling. The number that belongs on your scoreboard is dollars scheduled with a date and a deposit or an insurance verification, divided by dollars diagnosed, measured inside 14 days of the exam.

Ten Points on 300 Plans Is $72,000

Run the full scenario on a general practice seeing 40 new patients a month. That is 480 new patients a year. Three hundred of them get a treatment plan beyond a cleaning, at an average of $2,400 presented, for $720,000 of diagnosed treatment annually.

At the 45% pooled industry average, that practice converts $324,000. At the 61% survey average, $439,200. The distance between those two practices is $115,200 a year of production, with the same patients walking through the same door. At the top-decile 75% figure in the Catalyst Index, it is $540,000, or $216,000 clear of the average practice.

Nobody moves 30 points in a year. Ten points is realistic, and ten points on $720,000 is $72,000 of additional production. Because your rent, your front desk, your hygiene salaries and your equipment notes are already paid for by the existing schedule, the incremental cost of that work is lab, supplies and a share of chair time, call it 32%. You keep about $48,960.

Put that next to the usual growth projects. At $6,000 a day of production, $72,000 is twelve extra clinical days you did not have to staff, market for, or open on a Saturday to get. A marketing spend that bought you twelve days of new production would cost real money and take a year to prove out. The conversion fix costs a definition change and two hours a month of someone reading a report.

And if you are on the other side of this, running 88% by your own count, that $48,960 is not available to you. Your money is in the plans you never presented.

Why 78% Happened in an Orthodontic Study and Not in Your Operatory

The National Dental PBRN finding is the most useful number in this entire article: 78% acceptance of the most highly recommended treatment plan, across 345 adults and 91 providers. Not one practice with a charismatic owner. Ninety-one providers.

What was different was structure. Patients were presented with a ranked recommendation, and the provider was clear about which plan was the best one. That is it. Acceptance tracked the clarity of the recommendation, not the persuasiveness of the person making it.

Most general practices do the opposite. They present options in a row, priced, with no ranking, because ranking feels like pressure and options feel like respect. The patient hears three prices and picks the smallest, which your software records as acceptance and your bank account records as a 40% dollar conversion. Giving a patient a menu is not informed consent. It is abdication, and it costs about $1,000 per plan.

The Levin Group survey data backs the structure gap: only 26.3% of dentists use written case-presentation scripts, and 67.3% fall short of the 90% target. We do not think everyone needs a script. We do think everyone needs a stated first recommendation, in one sentence, before any number is spoken out loud.

The Denominator Nobody Audits

Now the uncomfortable part, and the reason we opened with the 85% claim.

Conversion rate is a fraction, and the fraction only reports on treatment you actually diagnosed and presented. Undiagnosed disease never appears as a failure. A practice that looks at a cracked molar, decides the patient seems price-sensitive, and says nothing has just improved its case acceptance rate.

The same Dental Economics research reports that only 63.2% of dentists perform annual comprehensive exams. Better than a third of practices are not systematically looking. Their conversion numbers are not measuring salesmanship. They are measuring the thin slice of dentistry that was obvious enough to mention.

This is why we will not congratulate an owner on a 90% number without seeing two other figures: diagnosed dollars per new patient exam, and the percentage of active patients with a completed comprehensive exam in the last 24 months. If diagnosed dollars per exam is low and your acceptance is sky-high, you are running a practice that sells what patients already asked for. That is a very comfortable business and a terrible asset to sell, because the next owner inherits a chart full of untouched need and no relationship history of raising it.

Nobody ever went broke presenting treatment. They went broke never presenting it, then putting a 92% acceptance rate in the front office newsletter.

What We'd Actually Put on the Scoreboard

Three numbers, reported monthly, on new patients only so the recall base does not blur the signal.

• Diagnosed dollars per new patient comprehensive exam. This is your denominator and your honesty check. Track it by provider. Spreads of 2x between associates in the same building are common and they are not about patient mix.
• Same-visit scheduled conversion, in dollars. Dollars with a date on them before the patient leaves the building, over dollars diagnosed. Our working expectation for a fee-for-service-leaning general practice is 50% to 65%. Below 40%, the presentation is broken. Above 85%, go back and check the denominator.
• Fourteen-day recovery. Dollars scheduled in the two weeks after the exam, from patients who left undecided. This is where a good treatment coordinator earns their entire salary, and most practices have no process for it at all.

One more thing we would kill: the 90% target. It is the number that teaches teams to stop diagnosing hard cases, and given that the national average sits 30 points below it, it functions as a permanent morale tax on people doing normal-to-good work. Set a target that is 8 points above your own trailing quarter and move it every quarter.

Three Moves Before Friday

Pull last quarter's new patient exams and calculate one number by hand: dollars scheduled within 14 days, divided by dollars diagnosed. Do it in a spreadsheet, not in your software's acceptance report, because the report is counting things you did not ask about. Then pick your single highest-value recurring case type and write one sentence that names your first recommendation before any price is said. If your hand-calculated number comes back above 85%, spend next week auditing comprehensive exam coverage instead of presentation skills.

We are watching one thing before we firm up the 50% to 65% range: whether same-visit scheduled conversion predicts 12-month collections per new patient better than acceptance rate does. If pooled data ever shows that high-acceptance practices also produce more per patient, the under-diagnosis theory in this piece is wrong and we will say so.

If you want to see what ten points of conversion would do to your own overhead percentage, put your fixed costs and current production into the free run your own numbers overhead calculator and add the incremental production on top. Fixed costs do not move when you schedule treatment you already diagnosed, so that extra production lands almost entirely in your overhead ratio and your take-home. It is the fastest way to see whether your conversion gap is a $15,000 problem or a $50,000 one.